SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently a major point of contention as investors debate whether the token's significant price decline represents a rare accumulation opportunity for high-utility infrastructure or a long-term value trap. While many community members are frustrated by the lack of price momentum compared to other altcoins, others are doubling down, citing its active role in institutional real-world asset tokenization and enterprise adoption as evidence that the technology remains disconnected from its current market valuation.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors focus on its decentralized GPU compute network and a revenue-sharing model that rewards stakers and node runners with real earnings. The community is actively discussing a potential supply shock, driven by the fact that a significant majority of the token supply is currently locked in long-term staking.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne is surging as a core beneficiary of the Nasdaq-100 rebalance, with the community highlighting its essential role as a testing "tollbooth" for the AI infrastructure supply chain. Investors are actively debating the stock's long-term valuation against other AI hardware leaders, noting that the index inclusion provides a structural catalyst for passive institutional demand.

Vishay Intertechnology, Inc. engages in the manufacture and distribution of discrete semiconductors and passive electronic components. It operates through the following segments: MOSFET (metal oxide semiconductor field-effect transistor), Diodes, Optoelectronic Components, Resistors, Inductors, and Capacitors. The MOSFET segment offers semiconductors which function as solid state switches to control power. The Diodes segment produces semiconductors which route, regulate, and block radio frequency, analog, and power signals, protect systems from surges or electrostatic discharge damage, and provide electromagnetic interference filtering. The Optoelectronic Components segment includes components that emit light, detect light, or do both. The Resistors and Inductors segment deals with components that impede electric current. The Capacitors segment provides components which store energy and discharge it when needed. The company was founded by Felix Zandman in 1962 and is headquartered in Malvern, PA.

Vishay Intertechnology, Inc.

Vishay Intertechnology is seeing intense institutional interest following a series of breakouts to fresh highs, with community discourse centered on its role as a critical supplier for semiconductor tooling and AI infrastructure. Investors are actively monitoring the stock's resilient technical structure and the broader thematic rotation into high-beta physical-layer leaders.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is trending as market participants closely monitor escalating geopolitical tensions surrounding the Strait of Hormuz and persistent uncertainty over U.S.-Iran diplomatic negotiations. The community is actively debating the durability of supply constraints, with many traders focused on how potential ceasefires or further military escalation will influence crude oil price volatility.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is experiencing heightened interest as investors shift focus toward potential mergers, acquisitions, and positive clinical trial readouts within the sector. Community sentiment is driven by a mix of optimism over sector rotation, strategic buying during pullbacks, and speculative excitement surrounding individual biotech firms that are gaining regulatory momentum.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

The Grayscale Ethereum Mini Trust is trending as institutional demand and shifting regulatory landscapes drive significant interest in Ethereum-linked vehicles. Community discussions remain heavily focused on macroeconomic triggers, such as inflation forecasts and central bank policy, alongside ongoing debates regarding the long-term viability of crypto-linked equities compared to direct asset ownership.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as investors gear up for quarterly earnings, fueled by significant insider buying from the CEO and strong momentum in the digital health sector. The community is actively debating the stock's recent rapid appreciation, balancing bullish enthusiasm for the company's membership growth and platform efficiency against concerns regarding valuation sustainability and volatility following a massive year-to-date run.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is capturing investor attention following its recent listings on major exchanges, driving speculation around its role in the real-world asset sector and its application in decentralized reinsurance markets. The community is actively debating the token's long-term utility, monitoring its ability to hold support levels, and analyzing the impact of its limited circulating supply.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors rally behind its vision as a decentralized, AI-native infrastructure for autonomous agents to own and manage code. The community is actively discussing the project's utility-focused tokenomics, including supply reduction plans, alongside potential exchange listings and strategic partnerships in the broader AI-crypto space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Codexis (CDXS) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of +9.09% and +1.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates

Fortrea Holdings Inc. (FTRE) delivered earnings and revenue surprises of +426.32% and -0.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Codexis (NASDAQ:CDXS) Lowered to "Hold" Rating by Wall Street Zen

Wall Street Zen cut shares of Codexis from a "buy" rating to a "hold" rating in a research report on Sunday...

Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Codexis (CDXS) Projected to Post Earnings on Thursday

Codexis (NASDAQ:CDXS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Codexis (NASDAQ:CDXS) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded Codexis from a "hold" rating to a "buy" rating in a research note on Saturday...

Codexis (NASDAQ:CDXS) Share Price Crosses Above 200-Day Moving Average   - What's Next?

Codexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving Average - What's Next...

Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 35.6% in March

Codexis, Inc. (NASDAQ:CDXS - Get Free Report) saw a significant drop in short interest in March. As of March 31st, there was short interest totaling 6,938,356 shares, a drop of 35.6% from the March...

537,833 Shares in Codexis, Inc. $CDXS Purchased by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 537,833 shares of the biotechnology company's stock, va...

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Codexis Inc.

Why Did CDXS Stock Jump 7% Today?

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.14	--	--	N/A
Q1 '26	-$0.14	-$0.10	26.83%	BEAT
Q4 '25	-$0.03	$0.11	466.67%	BEAT
Q3 '25	-$0.15	-$0.22	-48.08%	MISSED
Q2 '25	-$0.19	-$0.16	15.15%	BEAT

CDXSCodexis Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CDXS News